In the early months of the COVID-19 pandemic, nearly 75% of hospitalized COVID patients received antibiotics on admission, ...

COVID-19 RNA may induce monocytes to develop cancer-fighting properties, potentially shrinking tumors in certain metastatic cancers. Patients resistant to prior immunotherapy showed the most benefit ...

A new study has found that receiving messenger RNA-based COVID-19 vaccines such as those from Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) could boost the survival rates of ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

In patients with AF and COVID-19 who receive DOAC, 30-day mortality risk is similar for nirmatrelvir/ritonavir and RdRp inhibitors.

The coronavirus disease 2019 (COVID-19) pandemic took a heavy toll on human life and health beginning in 2020. Though the severity of the pandemic has faded, its long-term sequelae continue to plague ...

Anna Blakney sits on the scientific advisory board and/or consults for Genvax Technologies, Replicate Biosciences and Pasture Biosciences. She receives funding from CIHR, CBRF, NSERC and CFI. Pieter ...